rethinkMushrooms Search
Menu
Research citation

Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China.

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China.

Journal of cancer research and clinical oncology, 144(11), 2177-2186

Citation

Zhang, Yiran; Zhang, Meng; Jiang, Yifei; Li, Xiulian; He, Yanli; Zeng, Pengjiao; Guo, Zhihua; Chang, Yajing; Luo, Heng; Liu, Yong; Hao, Cui; Wang, Hua; Zhang, Guoqing; Zhang, Lijuan. (2018). Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China.. Journal of cancer research and clinical oncology, 144(11), 2177-2186. https://doi.org/10.1007/s00432-018-2718-1